Roberta Pantani

Roberta Pantani is an experienced regulatory affairs professional currently serving as Vice President of Regulatory Affairs at Calcilytix Therapeutics Inc., a BridgeBio Company, since July 2022. Prior to this role, Roberta was the Senior Director of Regulatory Affairs at Calcilytix from February 2020 to July 2022. Roberta has held various leadership positions in regulatory affairs, including Director of Regulatory Affairs at Myovant Sciences and Senior Director roles at Raptor Pharmaceuticals, Relypsa, and Cell Therapeutics, Inc. Roberta's career in regulatory affairs began at Farmila-Thea Farmaceutici, where responsibilities included roles in the Medical Department and Regulatory Affairs. Roberta holds a degree in Biology from Università degli Studi di Milano.